Literature DB >> 4729927

Experimental hepatic necrosis: studies on coagulation abnormalities, plasma clearance, and organ distribution of 125I-labelled fibrinogen.

M O Rake, P T Flute, G Pannell, K B Shilkin, R Williams.   

Abstract

Studies in the rat with hepatic necrosis induced by carbon tetrachloride showed that the abnormalities in one-stage coagulation tests and the increased catabolism of fibrinogen were similar to those found in man with acute viral or drug-induced hepatic necrosis. Determination of the distribution of the radioactive label shows that excessive deposition was maximal in the liver but also occurred in the spleen. The appearance is delayed by heparin but accelerated by tranexamic acid.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4729927      PMCID: PMC1412798          DOI: 10.1136/gut.14.7.574

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  JAUNDICE AND ITS RELATION TO THERAPEUTIC AGENTS.

Authors:  G C COOK; S SHERLOCK
Journal:  Lancet       Date:  1965-01-23       Impact factor: 79.321

2.  Hemostatic mechanisms in liver disease.

Authors:  O D RATNOFF
Journal:  Med Clin North Am       Date:  1963-05       Impact factor: 5.456

3.  The effect of diet and 1,1,1-trichloro-2,2-bis-(p-chlorophenyl)ethane (DDT) on microsomal hydroxylating enzymes and on sensitivity of rats to carbon tetrachloride poisoning.

Authors:  A E McLean; E K McLean
Journal:  Biochem J       Date:  1966-08       Impact factor: 3.857

4.  IN VIVO BEHAVIOR OF I-FIBRINOGEN.

Authors:  A S McFarlane
Journal:  J Clin Invest       Date:  1963-03       Impact factor: 14.808

5.  Intravascular coagulation in acute hepatic necrosis.

Authors:  M O Rake; P T Flute; G Pannell; R Williams
Journal:  Lancet       Date:  1970-03-14       Impact factor: 79.321

Review 6.  Iodine-labelled fibrinogen: a review.

Authors:  E Regoeczi
Journal:  Br J Haematol       Date:  1971-06       Impact factor: 6.998

7.  Coagulation factors in chronic liver disease.

Authors:  G W Donaldson; S H Davies; A Darg; J Richmond
Journal:  J Clin Pathol       Date:  1969-03       Impact factor: 3.411

8.  An electron microscopic study of thrombin-induced disseminated intravascular coagulation.

Authors:  W Margaretten; I Csavossy; D G McKay
Journal:  Blood       Date:  1967-02       Impact factor: 22.113

9.  Early and intensive therapy of intravascular coagulation in acute liver failure.

Authors:  M O Rake; P T Flute; K B Shilkin; M L Lewis; J Winch; R Williams
Journal:  Lancet       Date:  1971-12-04       Impact factor: 79.321

  9 in total
  6 in total

1.  Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy.

Authors:  B G Gazzard; J M Henderson; R Williams
Journal:  Gut       Date:  1975-08       Impact factor: 23.059

2.  Behaviour of 125I-fibrinogen and 131I-albumin in experimental galactosamine-induced hepatitis.

Authors:  I Mahn; H Merkel; E L Sattler; G Müller-Berghaus
Journal:  Gut       Date:  1977-07       Impact factor: 23.059

3.  Fibrin formation during asanguinous normothermic perfusion of the isolated rat liver.

Authors:  S Duca; A Suciu; C Duca; I Szantay; M Schwartz; R Lezeu
Journal:  World J Surg       Date:  1978-03       Impact factor: 3.352

Review 4.  Role of hemostatic factors in hepatic injury and disease: animal models de-liver.

Authors:  A K Kopec; N Joshi; J P Luyendyk
Journal:  J Thromb Haemost       Date:  2016-05-10       Impact factor: 5.824

5.  Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III.

Authors:  K Fujiwara; I Ogata; Y Ohta; K Hirata; Y Oka; S Yamada; Y Sato; N Masaki; H Oka
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

Review 6.  Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association?

Authors:  Anna K Kopec; James P Luyendyk
Journal:  Semin Thromb Hemost       Date:  2016-05-04       Impact factor: 4.180

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.